These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. Effect of lysosomal cationic proteins from polymorphonuclear leukocytes upon the fibrinogen and fibrinolysis system. Saba HI; Herion JC; Walker RI; Roberts HR Thromb Res; 1975 Oct; 7(4):543-54. PubMed ID: 811 [No Abstract] [Full Text] [Related]
2. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery. Nishiyama T; Yokoyama T; Yamashita K J Anesth; 2006; 20(3):179-82. PubMed ID: 16897236 [TBL] [Abstract][Full Text] [Related]
3. Anti-heparin activity of lysosomal cationic proteins from polymorphonuclear leukocytes. Saba HI; Roberts HR; Herion JC Blood; 1968 Mar; 31(3):369-80. PubMed ID: 5640632 [No Abstract] [Full Text] [Related]
4. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood]. Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381 [TBL] [Abstract][Full Text] [Related]
5. Biological activities of leupeptins. Aoyagi T; Miyata S; Nanbo M; Kojima F; Matsuzaki M J Antibiot (Tokyo); 1969 Nov; 22(11):558-68. PubMed ID: 4243683 [No Abstract] [Full Text] [Related]
6. Characterization of a neutral protease from lysosomes of rabbit polymorphonuclear leucocytes. Davies P; Rita GA; Krakauer K; Weissmann G Biochem J; 1971 Jul; 123(4):559-69. PubMed ID: 5126908 [TBL] [Abstract][Full Text] [Related]
7. Secretion of a proteolytic anticoagulant by Ancylostoma hookworms. Hotez PJ; Cerami A J Exp Med; 1983 May; 157(5):1594-603. PubMed ID: 6343546 [TBL] [Abstract][Full Text] [Related]
8. Selected hemostatic abnormalities associated with neoplastic disease. Ito R; Statland BE Clin Lab Med; 1982 Sep; 2(3):599-625. PubMed ID: 6814812 [No Abstract] [Full Text] [Related]
9. Isolation and characterization of granulocyte lysosomal proteins and study of their effects on the clotting system. Herion JC; Bucher JR; Penniall R; Walker RI; Baker M; Roberts HR Am J Hematol; 1979; 7(3):265-79. PubMed ID: 547740 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of cimetidine and epsilon-aminocaproic acid on fibrinolysis induced by activators of plasminogen and on fibrin formation. Jespersen J; Sidelmann J Thromb Res; 1981 May; 22(3):287-93. PubMed ID: 7197813 [No Abstract] [Full Text] [Related]
12. [Effect of the enzyme preparation longolytin on fibrinolysis in animals]. Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406 [TBL] [Abstract][Full Text] [Related]
13. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates. Skoza L; Tse AO; Semar M; Johnson AJ Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440 [No Abstract] [Full Text] [Related]
14. Failure of fibrinogen degradation products to increase plasma fibrinogen in rabbits. Otis PT; Rapaport SI Proc Soc Exp Biol Med; 1973 Oct; 144(1):124-9. PubMed ID: 4272418 [No Abstract] [Full Text] [Related]
15. Experimental production of microangiopathic haemolytic anaemia in vivo. Rubenberg ML; Bull BS; Regoeczi E; Dacie JV; Brain MC Lancet; 1967 Nov; 2(7526):1121-3. PubMed ID: 4168559 [No Abstract] [Full Text] [Related]